id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2026-N-4390-0048,FDA,FDA-2026-N-4390,AI-Enabled Optimization of Early-Phase Clinical Trials Pilot Program; Request for Information; Extension of Comment Period,Notice,Extension of Comment Period,2026-05-28T04:00:00Z,2026,5,2026-05-28T04:00:00Z,,2026-05-28T17:26:35Z,2026-10602,0,0,09000064b92f8788
FDA-2026-N-4390-0042,FDA,FDA-2026-N-4390,Request for Extension from Alliance for Regenerative Medicine,Other,Request for Extension,2026-05-21T04:00:00Z,2026,5,2026-05-21T04:00:00Z,,2026-05-22T00:11:13Z,,0,0,09000064b92e5fb3
FDA-2026-N-4390-0001,FDA,FDA-2026-N-4390,AI-Enabled Optimization of Early- Phase Clinical Trials Pilot Program; Request for Information,Notice,Requests for Information (RFI),2026-04-29T04:00:00Z,2026,4,2026-04-29T04:00:00Z,2026-06-30T03:59:59Z,2026-07-01T09:00:25Z,2026-08281,0,0,09000064b92b54c8